secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2026-03-26T23:59:59+00:00
Accession:  0001104659-26-035256
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics updates ATM program; $131.6M remaining under $150M facility
--------------------------------------------------------------------------------

- New prospectus supplement filed March 26, 2026 for existing ATM program under effective shelf.
- Up to $150M in common stock may be sold via ATM; $18.38M already sold.
- $131.62M remains available for future issuance through TD Securities as agent.
- Goodwin Procter LLP opinion on share validity included as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926035256/0001104659-26-035256-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926035256/tm269823d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-035256

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer